Stocks News

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Dec 3, 2024
- DJ Update: Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results -- Barrons.com, from 11:20AM ET on Tuesday Dec 03, 2024 by Dow Jones
  11:20AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: VIR, JANX
  
  By Mackenzie Tatananni
  
  Janux Therapeutics stock surged Tuesday after the company found success during a Phase I trial for a novel prostate cancer treatment.
  
  Shares of the California-based biopharmaceutical company climbed 63% to $65.59, snapping a five-day losing streak, after Janux reported promising results during a Phase I clinical trial for JANX007, a treatment for patients with advanced-stage prostate cancer.
- DJ Janux Therapeutics Stock Soars 70% on Prostate Cancer Drug Trial Results -- Barrons.com, from 10:39AM ET on Tuesday Dec 03, 2024 by Dow Jones
  10:39AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: VIR, JANX
  
  By Mackenzie Tatananni
  
  Janux Therapeutics stock surged Tuesday after the company found success during a Phase I trial for a novel prostate cancer treatment.
  
  Shares of the California-based biopharmaceutical company climbed 70% to $68.28 Monday, snapping a five-day losing streak, after Janux reported promising results during a Phase I clinical trial for JANX007, a treatment for patients with advanced-stage prostate cancer.
Nov 26, 2024
- Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN(TM) Masked T-Cell Engager Programs, from 9:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
  9:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: VIR
  
  Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN(TM) Masked T-Cell Engager Programs
  SAN FRANCISCO--(BUSINESS WIRE)--November 26, 2024--
  Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will host a virtual investor event to discuss initial data from the dual-masked Phase 1 T-cell engagers VIR-5818 targeting a variety of HER2-expressing solid tumors and VIR-5500 targeting PSMA in metastatic castration-resistant prostate cancer (mCRPC) along with updates on the PRO-XTEN(TM) platform on January 8, 2025, at 5:00 a.m. PT / 8:00 a.m. ET.
Nov 25, 2024
- Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference, from 9:30AM ET on Monday Nov 25, 2024 by Dow Jones
  9:30AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: VIR
  
  Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
  SAN FRANCISCO--(BUSINESS WIRE)--November 25, 2024--
  Vir Biotechnology Inc. (NASDAQ: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday December 3, at 6:10 a.m. PT / 9:10 a.m. ET in Miami, Florida.
Nov 20, 2024
- DJ Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co., from 10:11AM ET on Wednesday Nov 20, 2024 by Dow Jones
  10:11AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: VIR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VIR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 20, 2024 10:11 ET (15:11 GMT)

Today
- Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting, from 16 minutes ago by PR Newswire
  16 minutes ago by PR Newswire
  Companies Mentioned: PSTX
- Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting, from 17 minutes ago by Dow Jones
  17 minutes ago by Dow Jones
  Companies Mentioned: PSTX
- Kuehn Law Encourages PSTX, BERY, PLL, and RKDA Investors to Contact Law Firm, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: PLL, BERY, PSTX, RKDA
Dec 6, 2024
- DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Dec 06, 2024 by Dow Jones
  9:30PM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: SLM, UTI, PBF, PSTX, VAL
- DJ PBF Energy, Poseida Therapeutics, and More Stocks See Action From Activist Investors -- Barrons.com, from 6:33PM ET on Friday Dec 06, 2024 by Dow Jones
  6:33PM ET on Friday Dec 06, 2024 by Dow Jones
  Companies Mentioned: SLM, UTI, PBF, PSTX, VAL
Dec 4, 2024
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders, from 12:24PM ET on Wednesday Dec 04, 2024 by Dow Jones
  12:24PM ET on Wednesday Dec 04, 2024 by Dow Jones
  Companies Mentioned: PSTX, GATO, AVTE
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq -- PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE), from 11:00AM ET on Wednesday Dec 04, 2024 by Dow Jones
  11:00AM ET on Wednesday Dec 04, 2024 by Dow Jones
  Companies Mentioned: MPAD, PSTX, GATO, AVTE
Dec 3, 2024
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, SUM, FVNNU, HUDA on Behalf of Shareholders, from 12:30AM ET on Tuesday Dec 03, 2024 by PR Newswire
  12:30AM ET on Tuesday Dec 03, 2024 by PR Newswire
  Companies Mentioned: PSTX, HUDA, SUM, FVNNU
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, SUM, FVNNU, HUDA on Behalf of Shareholders, from 12:30AM ET on Tuesday Dec 03, 2024 by Dow Jones
  12:30AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: PSTX, HUDA, SUM
Dec 2, 2024
- Piper Sandler Downgrades Poseida Therapeutics to Neutral, $10 Price Target, from 9:03AM ET on Monday Dec 02, 2024 by MT Newswires
  9:03AM ET on Monday Dec 02, 2024 by MT Newswires
  Companies Mentioned: PSTX

Vir Biotechnology Inc
NASDAQ:VIRUnited States

Search Criteria

Dec 3, 2024

DJ Update: Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results -- Barrons.com, from 11:20AM ET on Tuesday Dec 03, 2024 by Dow Jones

DJ Janux Therapeutics Stock Soars 70% on Prostate Cancer Drug Trial Results -- Barrons.com, from 10:39AM ET on Tuesday Dec 03, 2024 by Dow Jones

Nov 26, 2024

Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN(TM) Masked T-Cell Engager Programs, from 9:30AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 25, 2024

Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference, from 9:30AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 20, 2024

DJ Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co., from 10:11AM ET on Wednesday Nov 20, 2024 by Dow Jones

Peers Headlines

Today

Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting, from 16 minutes ago by PR Newswire

Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting, from 17 minutes ago by Dow Jones

Kuehn Law Encourages PSTX, BERY, PLL, and RKDA Investors to Contact Law Firm, from 3 hours ago by Dow Jones

Dec 6, 2024

DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Dec 06, 2024 by Dow Jones

DJ PBF Energy, Poseida Therapeutics, and More Stocks See Action From Activist Investors -- Barrons.com, from 6:33PM ET on Friday Dec 06, 2024 by Dow Jones

Dec 4, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders, from 12:24PM ET on Wednesday Dec 04, 2024 by Dow Jones

Dec 3, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, SUM, FVNNU, HUDA on Behalf of Shareholders, from 12:30AM ET on Tuesday Dec 03, 2024 by PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, SUM, FVNNU, HUDA on Behalf of Shareholders, from 12:30AM ET on Tuesday Dec 03, 2024 by Dow Jones

Dec 2, 2024

Piper Sandler Downgrades Poseida Therapeutics to Neutral, $10 Price Target, from 9:03AM ET on Monday Dec 02, 2024 by MT Newswires